The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
MPN Workshop of the Carolinas 2024 | The role of interferon in the treatment of accelerated/blast phase MPN
Anand Patel, MD, University of Chicago Medical Center, Chicago, IL, discusses the potential role of interferon in accelerated/blast-phase myeloproliferative neoplasms (MPN-AP/BP). While he states that the role of interferon may be limited in the treatment of MPN-AP/BP, Dr Patel examines the potential of interferon for the prevention of disease. He suggests anticlonal therapies, including interferon-based therapies, could be used in high-risk chronic-phase MPNs to prevent the progression of disease into AP/BP. This interview took place at the 1st Annual MPN Workshop of the Carolinas in Asheville, NC.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Honoraria:BMS, AbbVie, Sobi; Research funding (institutional): Pfizer, Sumitomo, Kronos Bio.
